Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders associated with progression to leukemia and poor survival. Clonal hematopoiesis in people without an MDS diagnosis carries an increased risk of cardiovascular death. Many clonally restricted mutations are shared between pat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Brunner, Andrew M., Blonquist, Traci M., Hobbs, Gabriela S., Amrein, Philip C., Neuberg, Donna S., Steensma, David P., Abel, Gregory A., Fathi, Amir T.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2017
Témata:
Myeloid Neoplasia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728287/
https://ncbi.nlm.nih.gov/pubmed/29296849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017010165
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky